Signaturefd, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 2,365 shares of REGN stock, worth $1.66 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,365

Previous 2,342 0.98%

Holding current value

$1.66 Million

Previous $2.46 Million 1.02%

% of portfolio

0.05%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$1024.09 - $1201.76 $23,554 - $27,640	23 Added 0.98%	2,365 $2.49 Million
Q2 2024 Jul 29, 2024	BUY	$883.2 - $1071.19 $81,254 - $98,549	92 Added 4.09%	2,342 $2.46 Million
Q1 2024 May 03, 2024	BUY	$902.69 - $993.35 $111,933 - $123,175	124 Added 5.83%	2,250 $2.17 Million
Q4 2023 Jan 31, 2024	BUY	$775.18 - $881.7 $41,859 - $47,611	54 Added 2.61%	2,126 $1.87 Million
Q3 2023 Nov 03, 2023	BUY	$692.45 - $844.37 $108,022 - $131,721	156 Added 8.14%	2,072 $1.71 Million
Q2 2023 Aug 01, 2023	SELL	$700.03 - $830.35 $49,702 - $58,954	-71 Reduced 3.57%	1,916 $1.38 Million
Q1 2023 Apr 28, 2023	BUY	$680.49 - $826.97 $85,061 - $103,371	125 Added 6.71%	1,987 $1.63 Million
Q4 2022 Jan 27, 2023	BUY	$705.89 - $766.39 $65,647 - $71,274	93 Added 5.26%	1,862 $1.34 Million
Q3 2022 Nov 08, 2022	BUY	$573.97 - $724.32 $142,344 - $179,631	248 Added 16.31%	1,769 $1.22 Million
Q2 2022 Aug 10, 2022	SELL	$548.35 - $738.84 $89,381 - $120,430	-163 Reduced 9.68%	1,521 $899,000
Q1 2022 May 02, 2022	BUY	$595.12 - $698.43 $88,672 - $104,066	149 Added 9.71%	1,684 $1.18 Million
Q4 2021 Jan 25, 2022	BUY	$543.48 - $670.97 $116,304 - $143,587	214 Added 16.2%	1,535 $969,000
Q3 2021 Oct 28, 2021	BUY	$574.03 - $680.96 $87,252 - $103,505	152 Added 13.0%	1,321 $799,000
Q2 2021 Jul 26, 2021	BUY	$472.8 - $558.54 $206,613 - $244,081	437 Added 59.7%	1,169 $653,000
Q1 2021 Apr 30, 2021	SELL	$446.73 - $548.2 $79,071 - $97,031	-177 Reduced 19.47%	732 $346,000
Q4 2020 Feb 11, 2021	BUY	$478.3 - $607.98 $22,001 - $27,967	46 Added 5.33%	909 $439,000
Q3 2020 Nov 03, 2020	BUY	$544.75 - $658.21 $25,058 - $30,277	46 Added 5.63%	863 $483,000
Q2 2020 Jul 30, 2020	BUY	$493.32 - $643.92 $121,356 - $158,404	246 Added 43.08%	817 $510,000
Q1 2020 Apr 23, 2020	BUY	$336.18 - $494.43 $94,802 - $139,429	282 Added 97.58%	571 $279,000
Q4 2019 Feb 05, 2020	BUY	$274.13 - $376.51 $23,301 - $32,003	85 Added 41.67%	289 $109,000
Q3 2019 Oct 16, 2019	SELL	$273.46 - $318.39 $21,876 - $25,471	-80 Reduced 28.17%	204 $57,000
Q2 2019 Jul 31, 2019	SELL	$299.6 - $414.82 $60,219 - $83,378	-201 Reduced 41.44%	284 $89,000
Q1 2019 May 09, 2019	SELL	$372.08 - $439.57 $197,574 - $233,411	-531 Reduced 52.26%	485 $199,000
Q4 2018 Feb 13, 2019	BUY	$335.82 - $403.04 $43,992 - $52,798	131 Added 14.8%	1,016 $379,000
Q3 2018 Nov 15, 2018	BUY	$351.14 - $408.51 $185,050 - $215,284	527 Added 147.21%	885 $358,000
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $56,350 - $68,308	198 Added 123.75%	358 $124,000
Q1 2018 May 08, 2018	BUY	$315.82 - $393.78 $50,531 - $63,004	160 New	160 $55,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account